Ian M. Cawich, MD

New, Longer 220 mm Length of Lutonix 035 Drug-Coated Balloon Reduces Cost at Arkansas Heart Hospital

11/27/2018

The newest device that we have been able to use has been the 220 mm length version of the Lutonix 035 drug-coated balloon (BD/Bard). We have used this product since it launched in August and have done six cases thus far, all with great...

The newest device that we have...

11/27/2018

Cath Lab Digest

Original Contribution

Clinical Outcomes and Cost Comparisons of Stent and Non-Stent Interventions in Infrainguinal Peripheral Artery Disease: Insights From the Excellence in Peripheral Artery Disease (XLPAD) Registry

12/28/2018

Scott Kinlay , MD;

Mujtaba M. Ali , MD, RPVI;

Bala Ramanan , MD, MBBS;

Shirling Tsai , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Subhash Banerjee , MD, FSCAI;

Tayo Addo , MD;

Mazen S. Abu-Fadel , MD;

Christopher T. Bajzer , MD;

Ian M. Cawich , MD;

Houman Khalili , MD;

Michael Luna , MD;

Khusrow Niazi , MD;

Anand Prasad , MD, FACC, FSCAI, RPVI;

Ehrin J. Armstrong , MD, MSc, FACC;

Nicolas W. Shammas , MD, MS, FACC, FSCAI, FACP, FSVM;

Osvaldo S. Gigliotti , MD;

Haekyung Jeon-Slaughter , PhD;

Bassel Bou Dargham , MD, BS;

Preeti Kamath , BDS, MHA;

Mazin I. Foteh , MD;

We present data on 2162 patients from the ongoing United States multicenter XLPAD registry between 2006-2016 to compare stent vs non-stent treatment outcomes and associated costs in FP interventions.

We present data on 2162 patients...

12/28/2018

Journal of Invasive Cardiology

Original Contribution

Racial Disparities in Risk for Major Amputation or Death After Endovascular Interventions for Peripheral Artery Disease: A LIBERTY 360 Study

05/28/2021

Dwight Dishmon , MD;

Ehrin J. Armstrong , MD, MSc, FACC;

Laiq Raja , MD, FACC, FSCAI;

Foluso A. Fakorede , MD;

Stefanos Giannopoulos , MD;

Aaron Horne Jr., MD;

George L. Adams , MD, MHS, MBA, FACC, FSCAI;

Ian M. Cawich , MD;

Jihad A. Mustapha , MD, FACC, FSCAI;

The aim of this study was to determine whether there are racial differences in outcomes of patients with PAD undergoing endovascular treatment.

The aim of this study was to...

05/28/2021

Video

Real World Strategies for Complex Lesions

08/14/2023

Zola N'Dandu , MD;

Ian M. Cawich , MD;

Pradeep K. Nair , MD, FACC, FSCAI;

Dr. Pradeep Nair is joined by Dr. Zola N’Dandu and Dr. Ian Cawich to discuss complex cases and share how BD’s innovative suite of products help them treat patients with peripheral arterial disease.

Dr. Pradeep Nair is joined by...

08/14/2023

Vascular Disease Management

Original Contribution

DIAMondback Atherectomy With OCT Visualization for Calcified PAD Lesions (DIAMOCT-PAD Study)

01/19/2022

Vukram Baruah , BS;

Austin McElroy , BS;

Andre Paixao , MD;

Marc D. Feldman , MD;

Leybi Ramirez-Kelly , MD, MPH;

Taylor Hoyt , PhD;

Tom Milner , PhD;

Ian M. Cawich , MD;

Cezar A. Iliescu , MD, FACC, FSCAI;

Konstantinos Marmagkiolis , MD, MBA, FACC, FSCAI;

Mehmet Cilingiroglu , MD;

Vasili Lendel , MD;

Ismail Dogu Kilic , MD;

In this study, we aimed to describe the immediate and long-term vascular effects of OAS in patients with peripheral arterial disease (PAD) and moderate to severely calcified lesions.

In this study, we aimed to...

01/19/2022

Journal of Invasive Cardiology